Join
Live feed
·
PRReleasevia Quantisnow
Ligand Pharmaceuticals Incorporated logo
Travere Therapeutics Inc. logo

Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS

ByQuantisnow·Wall Street's wire, on your screen.
LGND· Ligand Pharmaceuticals IncorporatedTVTX· Travere Therapeutics Inc.
Health Care
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS | Quantisnow